On February 11th, we invited Professeur Dohun Kwon, who is researching TRPV1 structural analysis, to conduct a related seminar at our headquarters.
Despite his busy schedule having just arrived from the États-Unis, the seminar provided an opportunity to discuss the latest research trends on TRPV1 and explore directions for collaboration on TRPV1 structural analysis research.
With many US companies and chercheurs récemment reaching a consensus that TRPV1 is the ultimate target for analgésique non narcotiques, it was a valuable time to discuss the challenges and possibilities encountered in researching many small molecules.
Sur la base de this meeting, both parties agreed to proceed with close collaboration on future research.
Nous tenons à remercier une fois encore Professeur Kwon for visiting RudaCure and look forward to meaningful research outcomes à l'avenir.
